Patents, Drug Prices, Clinical Trials and the Economics of Medicine | IPWatchdog Unleashed
Briefly

Patents, Drug Prices, Clinical Trials and the Economics of Medicine | IPWatchdog Unleashed
"Brent Bellows stated, 'I use my PhD and the skills I developed in graduate school at the lab bench every single day.' This fluency allows him to operate where the legal and technical questions converge, particularly in the development of patent portfolios built with future ANDA and biosimilar litigation in mind."
"Having seen patent disputes from inside chambers, Brent came away with a sharper sense of what actually matters to judges. He emphasized that federal judges are ultimately focused on the record, the story of the invention and whether the arguments remain coherent from prosecution through litigation."
Brent Bellows combines a Ph.D. in human genetics with extensive experience in patent law to navigate the life sciences patent landscape. His scientific background informs his legal practice, emphasizing that patents are vital business assets. He highlights the importance of coherent narratives in patent disputes, shaped by his experience clerking in federal court. This perspective allows him to develop strategic patent portfolios that anticipate future litigation challenges, particularly in the pharmaceutical and biotechnology sectors.
[
|
]